SCHEMBL3573281

SCHEMBL3573281

Cc1ccc(S(=O)(=O)Oc2cccc(C(C)N(C)C)c2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 7/20 0.50
BCHE P06276 6/20 0.47
MAOB P27338 1/20 0.46
ALDH1A1 P00352 4/20 0.46
FAAH O00519 1/20 0.46
HPGD P15428 2/20 0.46
LMNA P02545 1/20 0.46
MEN1 O00255 2/20 0.45
KMT2A Q03164 2/20 0.45
MAPT P10636 3/20 0.43
NPSR1 Q6W5P4 2/20 0.43
HTT P42858 2/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
GPR17 Q13304 1/20 0.42
MARK4 Q96L34 1/20 0.41
GAA P10253 1/20 0.41
G6PD P11413 1/20 0.41
DRD2 P14416 1/20 0.41
DRD1 P21728 1/20 0.41
DRD4 P21917 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1826892 0.85 ALDH1A1 (0.47) MAOBALDH1A1HPGDLMNAMEN1
SCHEMBL1823209 0.83 MEN1 (0.50) MAOBALDH1A1HPGDLMNAMEN1
SCHEMBL1824906 0.83 MEN1 (0.53) ALDH1A1HPGDLMNAMEN1KMT2A
SCHEMBL1825788 0.82 ALDH1A1 (0.47) MAOBALDH1A1HPGDLMNAMEN1
SCHEMBL1825360 0.82 ALDH1A1 (0.46) MAOBALDH1A1HPGDLMNAMEN1
SCHEMBL2838551 0.81 ALDH1A1 (0.48) MAOBALDH1A1HPGDLMNAMEN1
SCHEMBL1825096 0.81 KMT2A (0.45) MAOBALDH1A1HPGDLMNAMEN1
SCHEMBL2838600 0.80 PTGS1 (0.56) MAOBALDH1A1HPGDLMNAMEN1
SCHEMBL1823066 0.80 MEN1 (0.47) MAOBALDH1A1HPGDLMNAMEN1
SCHEMBL1824984 0.80 DRD2 (0.50) MAOBALDH1A1HPGDLMNAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7714157-B2 Process for preparing a biaryl compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-05-11 US disclosed
US-20070270603-A1 Process for preparing a biaryl compound SUMITOMO CHEMICAL COMPANY, LIMITED 2007-11-22 US disclosed
US-7271280-B2 Process for preparing a biaryl compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-09-18 US disclosed
US-20040158093-A1 Process for preparing a biaryl compound SUMITOMO CHEMICAL COMPANY, LIMITED 2004-08-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040158093-A1 Process for preparing a biaryl compound CYP1B1, REL, CYP2F1 ACHE 3905/4885BCHE 1041/4885MAOB 334/4885
US-20070270603-A1 Process for preparing a biaryl compound CYP4A11, CYP4B1, CYP51A1 ACHE 565/4885BCHE 99/4885MAOB 107/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.